Literature DB >> 1534721

The facet syndrome. Myth or reality?

R P Jackson1.   

Abstract

The lumbar facet joint has long been considered a significant source of low back pain (LBP). Facet blocks with anesthetic and cortisone, and even facet denervation procedures, have been recommended as treatment for patients with LBP. The literature, however, fails to conclusively document the role of the facet in the production of LBP. Based on a review of the literature and the author's clinical studies, the following statements appear to be appropriate and defensible: (1) The lumbar facet joints are very important biomechanically. (2) The facet is not a common or clear source of significant pain. (3) The facet syndrome is not a reliable clinical diagnosis. (4) Injection of intraarticular saline into the facets in control cases is as effective as local anesthetic and steroids in relieving the patient's pain temporarily. (5) Response to facet joint injection in patients with LBP does not correlate with or predict their clinical results after solid posterior lumbar fusion, and it should not be used preoperatively as a clinical criterion in selection of patients for fusion. (6) More prospective, controlled and randomized clinical studies are recommended.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534721

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

Review 1.  The lumbar facet joint: a review of current knowledge: Part II: diagnosis and management.

Authors:  Gerard P Varlotta; Todd R Lefkowitz; Mark Schweitzer; Thomas J Errico; Jeffrey Spivak; John A Bendo; Leon Rybak
Journal:  Skeletal Radiol       Date:  2010-06-26       Impact factor: 2.199

2.  A classification system for the assessment of lumbar pain in athletes.

Authors:  J F Heck; J M Sparano
Journal:  J Athl Train       Date:  2000-04       Impact factor: 2.860

3.  The short- and mid-term effect of dynamic interspinous distraction in the treatment of recurrent lumbar facet joint pain.

Authors:  Mario Cabraja; Alexander Abbushi; Christian Woiciechowsky; Stefan Kroppenstedt
Journal:  Eur Spine J       Date:  2009-11       Impact factor: 3.134

4.  The impact of sagittal balance on low back pain in patients treated with zygoapophysial facet joint injection.

Authors:  L Proietti; G R Schirò; S Sessa; L Scaramuzzo
Journal:  Eur Spine J       Date:  2014-09-12       Impact factor: 3.134

5.  Parameters in electrode positioning in thoracic percutaneous facet denervation: an anatomical study.

Authors:  R J Stolker; A C Vervest; G J Groen
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 6.  Facet joint pain--advances in patient selection and treatment.

Authors:  Steven P Cohen; Julie H Y Huang; Chad Brummett
Journal:  Nat Rev Rheumatol       Date:  2012-11-20       Impact factor: 20.543

7.  Minimally invasive facet restoration implant for chronic lumbar zygapophysial pain: 1-year outcomes.

Authors:  Hans-Jörg Meisel; Konrad Seller; Achim L Th; Karin B Ttner-Janz; Peter Stosberg; Alexander Moser; Larry E Miller; Jon E Block; Luiz Pimenta
Journal:  Ann Surg Innov Res       Date:  2014-10-18

8.  Characterization of degenerative human facet joints and facet joint capsular tissues.

Authors:  J-S Kim; M H Ali; F Wydra; X Li; J L Hamilton; H S An; G Cs-Szabo; S Andrews; M Moric; G Xiao; J H-C Wang; Di Chen; J M Cavanaugh; H-J Im
Journal:  Osteoarthritis Cartilage       Date:  2015-06-25       Impact factor: 6.576

9.  Prevalence and clinical features of lumbar zygapophysial joint pain: a study in an Australian population with chronic low back pain.

Authors:  A C Schwarzer; S C Wang; N Bogduk; P J McNaught; R Laurent
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

10.  Management of occupational back pain: the Sherbrooke model. Results of a pilot and feasibility study.

Authors:  P Loisel; P Durand; L Abenhaim; L Gosselin; R Simard; J Turcotte; J M Esdaile
Journal:  Occup Environ Med       Date:  1994-09       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.